Distribution Collaboration Expands Markets for PET Infusion System

Bayer HealthCare (Leverkusen, Germany; Tarrytown, NY, USA) is enlarging its global distribution network for the marketing of the Medrad Intego positron emission tomography (PET) infusion system through a new distribution agreement with Comecer, SPA (Castel Bolognese, Italy), a world leader in nuclear medicine protection technologies.

Through this agreement, Bayer and Comecer will provide customers with an integrated nuclear medicine imaging system, combining the clinical administration capabilities of Intego with the Comecer’s protection technologies for PET/computed tomography (PET/CT) centers worldwide.

According to Doug Descalzi, Bayer HealthCare’s senior director of molecular imaging devices, this distribution agreement capitalizes on the strength of both companies. “This arrangement creates an end-to-end solution for customers, from isotope production to radiopharmaceutical infusion. We’re pleased to be working with Comecer to not only provide greater patient access to Intego but also to provide comprehensive product solutions to nuclear medicine suites around the world.”

Intego is a worldwide market leader in PET/CT, and the only US. Food and Drug Administration (FDA)-cleared system for administration of 18F-fluorodeoxyglucose (FDG) and 18F-sodium fluoride (NaF). Intego infuses doses on-demand, providing clinicians with enhanced workflow, greater flexibility, added protection and more effective, repeatable, patient-specific dosing. Now, through distribution with Comecer, European clinicians and other markets will have easier access to this radiation dose-reducing modality.

“Bayer has demonstrated incredible benefits to nuclear medicine facilities with the Intego PET infusion system,” said Emiliano Spagnolo, director of sales and business development for Comecer. “We are thrilled to take part in extending Intego to customers as part of our portfolio of solutions.”

Bayer HealthCare, since its launch in 2008, has continued to enhance the Intego platform, adding software features, expanding compatibility and indications, and substantially reducing the size of the device. Bayer HealthCare is presenting the Intego PET infusion system at the European Congress of Radiology (ECR) in Vienna (Austria), March 7-11, 2013.

Comecer Group is a developer of protection technologies, hot cells manufacturing for nuclear medicine, isolation technology, and nuclear power plant protection/decommissioning. Comecer Group also produces screening software systems and equipment for special applications, designed for large industrial groups and research organizations. The company works for hospitals, universities, and pharmaceutical companies on customized projects for the production of isolators for the treatment of toxic and hazardous substances.

The Bayer Group is a global enterprise with core competencies in healthcare, agriculture, and high-tech materials. Bayer HealthCare, a subgroup of Bayer, AG, is one of the world’s leading, innovative companies in the healthcare and medical products industry.

Related Links:
Bayer HealthCare
Comecer